From June 21 to June 30, 2025, 4 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA).
The technical requirements for the 4 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.
Hydroxytyrosol is a phenylethanol derivative and a phytochemical compound found in olive oil and olive leaves derived from the olive tree. It possesses good lipid and water solubility, along with strong antioxidant activity. According to CosIng, its manufacturing process is generally described as organic synthesis. It is classified as a skin conditioning agent and a bleaching agent in terms of cosmetic functions.
Hydroxytyrosol is one of the more popular ingredients among NCIs, with four separate notification submitted by different companies. The most recent applicant, Freda Biotechnology, focuses on the industrialization of fermentation-based ingredients developed through synthetic biology. The company is a key player in the industrialization of hyaluronic acid in China. It has well-known skincare brands such as Rellet and Dr. Alva.
*Pic source: Official website of Freda
Naematelia aurantialba is a precious edible mushroom native to Yunnan, China, and an endemic species of the Himalayas and the Hengduan Mountains. It is rich in proteins, carbohydrates, over 20 types of amino acids, as well as abundant minerals and vitamins. Known for both its culinary and medicinal value, Naematelia aurantialba contains a variety of bioactive compounds such as polysaccharides, aurantialbin, alkaloids, flavonoids, and glycosides. These constituents are believed to help enhance immune and hematopoietic functions, and have demonstrated significant effects in liver protection, anti-radiation, and anti-inflammatory applications.
This marks the sixth public notification of Naematelia Aurantialba Fruiting Body Extract as an NCI.
Akkermansia muciniphila (AKK) is a commensal bacterium naturally found in the human gut. Research has shown that AKK plays a unique role in areas such as metabolic disorders, cancer, and immunotherapy. In recent years, it has gained popularity as a "star gut microbe." In the health food sector, AKK has already been developed into a variety of products, including capsules and tablets.
The ingredient(Notification 20250081) belongs to the class of phosphatidylcholine compounds and is a type of synthetic phospholipid. A structurally similar compound, 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC), is primarily used in the pharmaceutical field for the preparation of liposomes, microbubble ultrasound contrast agents, and lipid microspheres. It is commonly employed to encapsulate drug molecules, particularly to address the delivery challenges of poorly soluble drugs and enhance their bioavailability. Based on its structure, it is inferred that this ingredient would function as a surfactant in cosmetic applications.
In this webinar, we will provide relevant analysis on the following points:
Market Section - China:
Current comparison of the development of the Chinese cosmetics market and the cosmetic ingredient market.
Comparison of the development of Chinese and international beauty companies: who has more opportunities?
Current status of imported cosmetics.
Updates of investment and financing in Chinese personal care-related companies.
Compliance Section - China:
What has happened in the first half of the year regarding cosmetic ingredients?
Current approval data for new cosmetic ingredients.
How to understand the updated management for IECIC?
Reminders on important considerations for new cosmetic ingredients applications.
REGISTER FOR FREE NOW: https://www.zmuni.com/en/event/13201/
